<?xml version="1.0" encoding="UTF-8"?>
<xml>
  <records>
    <record>
      <source-app name="Horizon">Horizon</source-app>
      <rec-number>1</rec-number>
      <foreign-keys>
        <key app="Horizon" db-id="fdi:010087053">1</key>
      </foreign-keys>
      <ref-type name="Journal Article">17</ref-type>
      <work-type>ACLN : Articles dans des revues avec comité de lecture non répertoriées par l'AERES</work-type>
      <contributors>
        <authors>
          <author>
            <style face="normal" font="default" size="100%">Drabo, S.</style>
          </author>
          <author>
            <style face="bold" font="default" size="100%">Ouattara, Fatoumata</style>
          </author>
          <author>
            <style face="bold" font="default" size="100%">Baxerres, Carine</style>
          </author>
          <author>
            <style face="bold" font="default" size="100%">Guillaume, Agnès</style>
          </author>
        </authors>
      </contributors>
      <titles>
        <title>Reproductive health governance : availability and professional use of misoprostol in Benin and Burkina Faso</title>
        <secondary-title>Nordic Journal of African Studies</secondary-title>
      </titles>
      <pages>224-244</pages>
      <keywords>
        <keyword>BENIN</keyword>
        <keyword>BURKINA FASO</keyword>
      </keywords>
      <dates>
        <year>2022</year>
      </dates>
      <call-num>fdi:010087053</call-num>
      <language>ENG</language>
      <periodical>
        <full-title>Nordic Journal of African Studies</full-title>
      </periodical>
      <isbn>1235-4481</isbn>
      <number>3</number>
      <urls>
        <related-urls>
          <url>https://www.documentation.ird.fr/hor/fdi:010087053</url>
        </related-urls>
        <pdf-urls>
          <url>https://horizon.documentation.ird.fr/exl-doc/pleins_textes/2024-01/010087053.pdf</url>
        </pdf-urls>
      </urls>
      <volume>31</volume>
      <remote-database-provider>Horizon (IRD)</remote-database-provider>
      <abstract>Misoprostol  is  effective  not  only  for  gastroenterology  indications  but  also  for  reproductive  health-related  conditions  and  for  the  reduction  of  maternal  mortality.  The  use  of  misoprostol  is  well  documented  in  Latin  America,  where  it  is  widely  used  for  abortions.  However,  scant  knowledge exists regarding its use in African contexts. In this study, we describe and analyse the conditions of the professional use of misoprostol in Benin and Burkina Faso. We ask the following questions : How accepted is misoprostol in Benin and Burkina Faso ? What was the process leading to the official recognition of misoprostol in both countries ? Which actors were involved  in  this  process ?  How  do  health  care  workers  perceive  and  use  misoprostol  in  the  context of care ? Theoretically, we use the concepts 'social life of medicine' and 'reproductive governance' to analyse the position of misoprostol within the broader system of health policy, as well as its professional usage within the health care system. The fieldwork conducted in Benin and Burkina Faso highlights the conditions of the institutional acceptability of the drug and the logics underlying the use and non-use of misoprostol by health workers in both countries. The article highlights the social life of misoprostol by showing how the governance surrounding its use contributes to the development and cultivation of suspicions towards the drug among health care providers and institutional actors - suspicions that consequently restrict the availability of misoprostol as a medical therapeutic option</abstract>
      <custom6>050MEDECI ; 056SOCSAN</custom6>
    </record>
  </records>
</xml>
